Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts

Insights

2'-deoxyguanosine toxicity in T lymphoblasts is mediated by elevated dATP levels, causing G1-phase arrest. This finding is crucial for understanding purine nucleoside phosphorylase (PNP) deficiency and developing PNP inhibitors.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Immunology

Background:

  • The toxicity of 2 -deoxyguanosine to lymphoid cells is relevant to purine nucleoside phosphorylase (PNP) deficiency and therapeutic strategies using PNP inhibitors.
  • Understanding the precise mechanism of this toxicity is crucial for both inherited immune disorders and drug development.

Purpose of the Study:

  • To investigate the cell cycle and biochemical effects of 2 -deoxyguanosine in human lymphoblasts using a PNP inhibitor.
  • To elucidate the specific deoxyribonucleotide pools responsible for G1-phase arrest induced by 2 -deoxyguanosine.

Main Methods:

  • Utilized human lymphoblasts and the PNP inhibitor 8-aminoguanosine to study 2 -deoxyguanosine effects.
  • Analyzed cell cycle progression (G1-phase arrest) and intracellular deoxyribonucleotide pool dynamics (dGTP and dATP).
  • Performed experiments with 2 -deoxycytidine to dissociate dGTP and dATP elevation.

Main Results:

  • Cytostatic concentrations of 2 -deoxyguanosine induced G1-phase arrest in PNP-inhibited T lymphoblasts.
  • 2 -Deoxyguanosine elevated both 2 -deoxyguanosine-5 -triphosphate (dGTP) and 2 -deoxyadenosine-5 -triphosphate (dATP) pools, leading to pyrimidine deoxyribonucleotide depletion.
  • The onset of G1-phase arrest correlated with increased dATP levels, not dGTP levels.
  • Elevated dGTP alone, without elevated dATP, did not halt cell cycle progression from G1 to S phase.

Conclusions:

  • The G1-phase arrest induced by 2 -deoxyguanosine in T lymphoblasts is primarily mediated by elevated dATP pools.
  • dATP appears to be the key mediator of both 2 -deoxyguanosine and 2 -deoxyadenosine toxicity in T lymphoblasts.
  • These findings enhance the understanding of PNP deficiency pathogenesis and inform the design of therapies involving PNP inhibition.

Related Concept Videos

GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...